Food Safety and Standards Authority of India has barred the use of ashwagandha leaves and their extracts in health supplements and related products, in a move aimed at tightening oversight of a widely used wellness ingredient, according to a report by Mint.
The regulator clarified that only the roots of ashwagandha and their extracts are permitted for use, and directed state authorities to take action against violations, as reported by Mint.
The decision follows safety concerns flagged by the Ministry of Ayush regarding the use of leaf extracts, as stated. Scientific studies cited in the report indicate that ashwagandha leaves contain higher levels of reactive withanolides, particularly withaferin-A, which may pose health risks including liver toxicity, gastrointestinal distress and potential neurotoxic effects.
In a communication dated April 16, reviewed by Mint, FSSAI instructed state authorities to maintain strict vigilance and initiate legal action against food business operators found using non-permitted plant parts, as reported. It also directed companies to clearly specify the plant part used on product labels.
The regulator noted that some manufacturers were using ashwagandha leaves and their extracts despite these not being permitted, adding that the Ministry of Ayush has mandated the use of only roots and root extracts, as informed. It further advised food business operators to ensure strict compliance, warning that violations would attract action under the Food Safety and Standards Act, 2006.
Ashwagandha has seen rising global demand, particularly in North America and Europe, where it is marketed as a leading adaptogen in formats such as gummies, capsules, tea blends and fortified beverages, as stated. In India, it is commonly positioned as a natural supplement aimed at boosting strength, stamina and sexual wellness, particularly among men.
According to the Mint report, the ashwagandha market is estimated to reach $928.5 million in 2026, while the broader nutraceutical sector is valued at approximately $38.77 billion and is projected to grow to $84.99 billion by 2033.
The herb is cultivated across multiple states including Madhya Pradesh, Rajasthan, Gujarat, Maharashtra, Uttar Pradesh, Punjab and Haryana, with total acreage estimated at around 10,780 hectares, as stated. Key companies offering ashwagandha-based products include Himalaya Wellness, Dabur India, Patanjali Ayurved, Baidyanath and Zandu.
Follow Storyboard18 on Google for the latest and breaking brand marketing and industry updates, along with in-depth coverage of digital news. Stay informed with the latest perspectives only on Storyboard18.
First Published on April 18, 2026, 19:46:02 IST